Fortis Group Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,807
Closed -$60.2K 516
2023
Q4
$60.2K Hold
17,807
0.01% 166
2023
Q3
$60.2K Buy
17,807
+107
+0.6% +$376 0.02% 133
2023
Q2
$69.7K Sell
17,700
-107
-0.6% -$339 0.02% 129
2023
Q1
$46.7K Buy
+17,807
New +$72.6K 0.01% 123

Other funds holding SRTA

Fortis Group Advisors's SRTA Position: Q1 2024 in Review

Fortis Group Advisors sold out of Strata Critical Medical Inc (SRTA) in Q1 2024, closing a stake of 17,807 shares — an estimated $60.2K sold.

Fortis Group Advisors first reported a position in SRTA in Q1 2023 and held it in 4 quarters. The position peaked at $69.7K in Q2 2023. 114 funds tracked by Wall St. Rank hold SRTA as of Q1 2024.

  • Fortis Group Advisors reported no remaining Strata Critical Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Fortis Group Advisors sold 17,807 Strata Critical Medical Inc shares in Q1 2024, an estimated $60.2K.
  • Fortis Group Advisors first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 4 quarters.
  • Fortis Group Advisors's Strata Critical Medical Inc position peaked at $69.7K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2024.

Based on Fortis Group Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.